ОбзорГрафикПрофильОсновная статистикаФинансовые показателиТехническийНовостиTraderScreen

Arch Capital Group Ltd/  BMG0450A1053  /

NASDAQ
28.05.2024  22:00:00 Изменение -1.1100 Объем сделки Бид10:00:05 Предложение10:00:05 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
102.2500USD -1.07% 1.72 млн
Оборот: 122.85 млн		 79.3500Величина цены спроса: 200 107.2800Величина цены предложения: 100 38.39 млрдUSD - 8.56
GlobeNewswire 13:02 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire 13:00 Gildan Activewear Reports on Shareholders’ Voting Results
GlobeNewswire 13:00 Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
TeleTrader 13:00 US mortgage applications down 5.7%
GlobeNewswire 13:00 Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
GlobeNewswire 13:00 Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
GlobeNewswire 13:00 Lotus Technology Reports Unaudited First Quarter 2024 Financial Results
GlobeNewswire 13:00 Bitfarms Responds to Unsolicited Proposal from Riot Platforms
GlobeNewswire 13:00 Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Br...
GlobeNewswire 13:00 Cielo Announces Appointment of New Auditor
GlobeNewswire 13:00 Athira Pharma to Participate in Upcoming June Conferences
GlobeNewswire 13:00 Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, ...
GlobeNewswire 13:00 Dragonfly Energy to Participate in June 2024 Conferences
GlobeNewswire 13:00 Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezata...
GlobeNewswire 13:00 Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
GlobeNewswire 13:00 Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 202...
GlobeNewswire 13:00 Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function ...
GlobeNewswire 13:00 Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabete...
GlobeNewswire 13:00 TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its ...
GlobeNewswire 13:00 Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 13:00 OTC Markets Group Welcomes Marpai, Inc. to OTCQX
GlobeNewswire 13:00 ProKidney to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire 13:00 Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
GlobeNewswire 13:00 Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024
GlobeNewswire 13:00 ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaki...